LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer.

Xi, Dayong; Jia, Qiufang; Liu, XiaoLong; Zhang, Lei; Xu, Bo; Ma, Zhen; Ma, YanLing; Yu, Yang; Zhang, Fan; Chen, Hao

Xi, Dayong; Jia, Qiufang; Liu, XiaoLong; Zhang, Lei; Xu, Bo; Ma, Zhen; Ma, YanLing; Yu, Yang; Zhang, Fan; Chen, Hao.

Afiliación

Xi D; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Jia Q; Department of Gastroenterology, The Second Provincial People's Hospital of Gansu, Lanzhou, Gansu, People's Republic of China.
Liu X; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Zhang L; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Xu B; The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Ma Z; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Ma Y; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Yu Y; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Zhang F; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Chen H; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.

Int J Gen Med ; 15: 3183-3198, 2022.

Article en En | MEDLINE | ID: mdl-35342300

Palabras clave

GC; LAMC1; bioinformatics; novel target; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Gen Med Año: 2022 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google